Found: 59
Select item for more details and to access through your institution.
<sup>18</sup>F-FDG Fetal Dosimetry Calculated with PET/MRI.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263561
- By:
- Publication type:
- Article
Positron emission tomography imaging of system x<sub>C</sub><sup>-</sup> in immune cells for assessment of disease activity in mice and patients with inflammatory bowel disease.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263289
- By:
- Publication type:
- Article
First-in-human evaluation of <sup>18</sup>F-SMBT-1, a novel <sup>18</sup>F-labeled MAO-B PET tracer for imaging reactive astrogliosis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263254
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
SIR-Spheres® activity measurements reveal systematic miscalibration.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262650
- By:
- Publication type:
- Article
Principles of Tracer Kinetic Analysis in Oncology, Part I: Principles and Overview of Methodology.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 342, doi. 10.2967/jnumed.121.263518
- By:
- Publication type:
- Article
Health Care and Nuclear Medicine in France.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 327, doi. 10.2967/jnumed.122.263863
- By:
- Publication type:
- Article
SNMMI LEADERSHIP UPDATE: Call the Nuclear Oncologist.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 15N
- By:
- Publication type:
- Article
SNMMI Launches Radiopharmaceutical Therapy Centers of Excellence Program.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 14N
- Publication type:
- Article
FDA Guidance on Patient Engagement in Medical Device Clinical Studies.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 13N
- Publication type:
- Article
CMS Proposes Medicare Coverage Policy for Monoclonal Antibody–Based Alzheimer Treatment.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 12N
- Publication type:
- Article
HFR Outage and Isotope Supply.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 13N
- Publication type:
- Article
SNMMI Reacts to CMS Coverage Decision.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 12N
- Publication type:
- Article
SNMMI Statement: Possible Effect of Omicron Infection on <sup>18</sup>F-FDG–Based Imaging
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 11N
- Publication type:
- Article
Robot-assisted prostate-specific membrane antigen-radioguided surgery in primary diagnosed prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1
- By:
- Publication type:
- Article
Letter to the Editor: "<sup>18</sup>F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study".
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.122.263837
- By:
- Publication type:
- Article
Tumor sink effect in <sup>68</sup>Ga-PSMA-11 PET: Myth or Reality?
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.122.263802
- By:
- Publication type:
- Article
Temporary reactive response of axillary lymph nodes to COVID-19 vaccination on <sup>18</sup>F-rhPSMA-7.3 PET/CT in patients with prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263758
- By:
- Publication type:
- Article
Virtual Biopsy: Just an AI Software or a Medical Procedure?
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263749
- By:
- Publication type:
- Article
Reply to 'Adding non-tumor radiomic features to the prognostic model is bothersome but useful'.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263730
- By:
- Publication type:
- Article
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms using <sup>68</sup>Ga-PentixaFor PET.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263693
- By:
- Publication type:
- Article
The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer -- Going Beneath the Surface with Molecular Imaging.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263684
- By:
- Publication type:
- Article
Why We Did What We Did: PSMA-PET/CT Selection Criteria for the VISION Trial.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263638
- By:
- Publication type:
- Article
mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263618
- By:
- Publication type:
- Article
The change in management by <sup>18</sup>F-DCFPyL PSMA PET scanning in patients undergoing post-prostatectomy radiotherapy, with early biochemical response outcomes.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263521
- By:
- Publication type:
- Article
Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with Magnetic Resonance Tissue Characterization and Subsequent Functional Outcome.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263555
- By:
- Publication type:
- Article
Administration Routes for SSTR- / PSMA- and FAP-directed Theranostic Radioligands in Mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263453
- By:
- Publication type:
- Article
Analysis of short term and stable DNA damage in patients with differentiated thyroid cancer treated with <sup>131</sup>I in hypothyroidism or with rhTSH for remnant ablation.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263442
- By:
- Publication type:
- Article
Proceedings: PET Drugs: A Workshop on Inspections Management and Regulatory Considerations.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263443
- By:
- Publication type:
- Article
Utility of <sup>18</sup>F-rhPSMA-7.3 positron emission tomography for imaging of primary prostate cancer and pre-operative efficacy in N-staging of unfavorable intermediate to very high-risk patients validated by histopathology.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263440
- By:
- Publication type:
- Article
Interrogating glioma-associated microglia/macrophage dynamics under CSF-1R therapy with multi-tracer in vivo PET/MR imaging.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263318
- By:
- Publication type:
- Article
Synthesis and Preclinical Evaluation of <sup>177</sup>Lu-labeled Radiohybrid PSMA Ligands (rhPSMAs) for Endoradiotherapy of Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263371
- By:
- Publication type:
- Article
Substitution of L-Trp by a-methyl-L-Trp in <sup>177</sup>Lu-RM2 results in <sup>177</sup>Lu-AMTG, a high affinity GRPR ligand with improved in vivo stability.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263323
- By:
- Publication type:
- Article
Radium 223 induces transient functional bone marrow toxicity.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263310
- By:
- Publication type:
- Article
Evaluation of Data-Driven Rigid Motion Correction in Clinical Brain PET Imaging.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263309
- By:
- Publication type:
- Article
Impact of ComBat harmonization on PET radiomics-based tissue classification: a dual-center PET/MR and PET/CT study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263102
- By:
- Publication type:
- Article
The impact of semi-automatic segmentation methods on metabolic tumor volume, intensity and dissemination radiomics in <sup>18</sup>F-FDG PET scans of patients with classical Hodgkin lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263067
- By:
- Publication type:
- Article
Assessing reactive astrogliosis with <sup>18</sup>F-SMBT-1 across the Alzheimer's disease spectrum.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263255
- By:
- Publication type:
- Article
Molecular imaging findings on acute and long-term effects of COVID-19 on the brain: A systematic review.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263085
- By:
- Publication type:
- Article
MIRD Pamphlet No. 27: MIRDcell V3, a revised software tool for multicellular dosimetry and bioeffect modeling.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263253
- By:
- Publication type:
- Article
Targeted Alpha-Emitter Therapy With <sup>212</sup>Pb-DOTAMTATE for the Treatment of Metastatic SSTRExpressing Neuroendocrine Tumors: First-in-Human, Dose-Escalation Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263230
- By:
- Publication type:
- Article
SV2A PET imaging is a non-invasive marker for the detection of spinal damages in experimental models of spinal cord injury.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263222
- By:
- Publication type:
- Article
Molecular imaging of Neuroendocrine Prostate Cancer by targeting Delta-like Ligand 3.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263221
- By:
- Publication type:
- Article
<sup>18</sup>F-PFPN PET: a new and attractive imaging modality for patients with malignant melanoma.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263179
- By:
- Publication type:
- Article
Prospective phase II trial of prognostication by 68Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263177
- By:
- Publication type:
- Article
In vivo evaluation of six analogs of 11C-ER176 as candidate 18F-labeled radioligands for translocator protein 18 kDa (TSPO).
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263168
- By:
- Publication type:
- Article
Dynamic Tumor-Specific MHC-II Immuno-PET Predicts Checkpoint Inhibitor Immunotherapy Efficacy in Melanoma Running title: MHC-II PET Imaging for Immunotherapy.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263151
- By:
- Publication type:
- Article
<sup>68</sup>Ga-DOTA-NT-20.3 Neurotensin receptor 1 positron emission tomography imaging as a surrogate for neuroendocrine differentiation of prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263132
- By:
- Publication type:
- Article
Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262622
- By:
- Publication type:
- Article
Safety of peptide receptor radionuclide therapy with <sup>177</sup>Lutetium DOTATATE in neuroendocrine tumour patients with chronic kidney disease.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263056
- By:
- Publication type:
- Article